This Week in Cell

A team from the UK, Denmark, and US explore the potential consequences that genetic variation might have on response to drugs targeting G-protein-coupled receptors (GPCRs). For their pharmacogenomic analysis, the researchers brought together genetic variation or mutation data representing drug-targeted GPCRs in almost 68,500 individuals from the Exome Aggregation Consortium, 1000 Genomes Project, or parent-child trios from other studies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.